Radionuclide intake risks in the clinical administration of 223RaCl2

An intake monitoring program covering more than half a year of clinical administration of Radium-223-dichloride for the palliative treatment of castration-resistant prostate cancer was carried out in the nuclear medicine department of the university hospital Bonn. Radioactivity in a total of 87 samp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of radiological protection 2019-06, Vol.39 (2), p.387-398
Hauptverfasser:	Scholl, Clemens, Bundschuh, Ralph A, Hirzebruch, Stefan, Glanert, Tim, Wei, Xiao, Kürpig, Stefan, Rödel, Roland, Essler, Markus, Thomas, Lena, Ahmadzadehfar, Hojjat
Format:	Artikel
Sprache:	eng
Schlagworte:	alpha-radiation CRPC intake factor intake risk Ra-223 Radium-223
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!